Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.

Published on Feb 1, 2019in Hormones and Cancer2.437
· DOI :10.1007/S12672-018-0354-5
Mauricio P. Pinto11
Estimated H-index: 11
(UC: Pontifical Catholic University of Chile),
Matias Munoz Medel2
Estimated H-index: 2
(UC: Pontifical Catholic University of Chile)
+ 22 AuthorsMarcelo Garrido21
Estimated H-index: 21
(UC: Pontifical Catholic University of Chile)
Neuroendocrine tumors (NETs) are relatively rare and highly heterogeneous neoplasms. Despite this, recent studies from North America and Central Europe have suggested an increase in incidence. In Latin America, NET data are scarce and scattered with only a few studies reporting registries. Our goal was to establish a NET registry in Chile. Here, we report the establishment and our first 166 NET patients. We observed a slight preponderance of males, a median age at diagnosis of 53 years and a median overall survival of 110 months. As anticipated, most tumors were gastroenteropancreatic (GEP). Survival analyses demonstrated that non-GEP or stage IV tumors presented significantly lower overall survival (OS). Similarly, patients with surgery classified as R0 had better OS compared to R1, R2, or no surgery. Furthermore, patients with elevated chromogranin A (CgA) or high Ki67 showed a trend to poorer OS; however, these differences did not reach statistical significance (log-rank test p = 0.07). To the best of our knowledge, this is the first report of a NET registry in Chile. Median OS in our registry (110 months) is in line with other registries from Argentina and Spain. Other variables including age at diagnosis and gender were similar to previous studies; however, our data indicate a high proportion of small-bowel NETs compared to other cohorts, reflecting the need for NET regional registries. Indeed, these registries may explain regional discrepancies in incidence and distribution, adding to our knowledge on this seemingly rare, highly heterogeneous disease.
Figures & Tables
📖 Papers frequently viewed together
83 Citations
14 Authors (Qing Zhong, ..., Chang-Ming Huang)
8 Citations
4 Authors (Jocelyn Reeders, ..., Mathew George)
1 Citations
#1Jin-Hu Fan (Peking Union Medical College)H-Index: 29
#2Yu-Qing Zhang (Peking Union Medical College)H-Index: 4
Last. You-Lin QiaoH-Index: 90
view all 15 authors...
// Jin-Hu Fan 1, * , Yu-Qing Zhang 1, * , Su-Sheng Shi 2 , Yuan-Jia Chen 3 , Xing-Hua Yuan 4 , Li-Ming Jiang 5 , Shao-Ming Wang 1 , Li Ma 6 , Yu-Tong He 7 , Chang-Yan Feng 8 , Xi-Bin Sun 9 , Qing Liu 10 , Katrina Deloso 11 , Yihebali Chi 12 and You-Lin Qiao 1 1 Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College 2 Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College 3 Depart...
29 CitationsSource
#1Raziye Boyar Cetinkaya (Oslo University Hospital)H-Index: 3
#1Raziye Boyar Cetinkaya (University of Oslo)H-Index: 1
Last. Svein HansenH-Index: 18
view all 6 authors...
Background: Epidemiological studies show an increasing trend in the incidence of neuroendocrine neoplasms (NENs). A significant number of NENs occur in less common primary sites, but they are often excluded from the population-based studies. We studied the incidence trends of all NENs in Norway according to different primary sites. Materials and Methods: Our analyses were based on cancer cases diagnosed between 1993 and 2010 and reported to the national population-based Cancer Registry of Norway...
52 CitationsSource
#1Susana Eyheramendy (UC: Pontifical Catholic University of Chile)H-Index: 24
#1S. Eyheramendy (UC: Pontifical Catholic University of Chile)
Last. Gabriela M. Repetto (Universidad del Desarrollo)H-Index: 20
view all 5 authors...
Chileans are genetically admixed. Here, the authors find that the average admixing time is around 10 generations ago and show the contribution of European men and Native-American women to the Chilean population.
77 CitationsSource
#1Julie Hallet (Sunnybrook Health Sciences Centre)H-Index: 10
#1Julie Hallet (Sunnybrook Health Sciences Centre)H-Index: 13
Last. Simron Singh (Sunnybrook Health Sciences Centre)H-Index: 27
view all 6 authors...
BACKGROUND An increased incidence of neuroendocrine tumors (NETs) has been reported worldwide, but the reasons underlying this rise have not been identified. By assessing patterns of metastatic presentation, this study sought to examine the epidemiologic characteristics of NETs and the contribution of early-stage detection to the rising incidence. METHODS A population-based retrospective cohort study was conducted with prospectively maintained databases linked at the Institute for Clinical Evalu...
369 CitationsSource
#1Tetsuhide Ito (Kyushu University)H-Index: 14
#1Tetsuhide Ito (Kyushu University)H-Index: 14
Last. Akira ShimatsuH-Index: 44
view all 12 authors...
Background Although neuroendocrine tumors (NETs) are rare, the number of patients with NET is increasing. However, in Japan, there have been no epidemiological studies on NET since 2005; thus, the prevalence of NET remains unknown.
182 CitationsSource
Last. Enrique RocaH-Index: 28
view all 27 authors...
Neuroendocrine tumors (NET) include a spectrum of malignancies arising from neuroendocrine cells throughout the body. The objective of this clinical investigation of retrospectively and prospectively collected data was to describe the prevalence, demographic data, clinical symptoms and methods of diagnosis of NET and the treatment and long-term follow-up of patients with NET. Data were provided by the participating centers and assessed for consistency by internal reviewers. All the cases were ce...
31 CitationsSource
#1Hui-Jen Tsai (NHRI: National Health Research Institutes)H-Index: 1
#1Hui-Jen Tsai (NHRI: National Health Research Institutes)H-Index: 9
Last. Jeffrey S. Chang (NHRI: National Health Research Institutes)H-Index: 31
view all 6 authors...
Background The epidemiology of neuroendocrine tumors (NETs) is not well illustrated, particularly for Asian countries.
94 CitationsSource
#1Ulrich-Frank Pape (Charité)H-Index: 28
#2Aurel PerrenH-Index: 74
Last. Ashley B. GrossmanH-Index: 126
view all 11 authors...
a Division of Hepatology and Gastroenterology, Department of Internal Medicine, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Berlin , Germany; b Department of Pathology, Universitatsspital, Zurich , Switzerland; c Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna , Austria; d Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem , Israel; e Department of Internal Medicine, Philipps University, Marburg , Germany;...
294 CitationsSource
#1Adele CaldarellaH-Index: 24
#2Emanuele CrocettiH-Index: 45
Last. Eugenio PaciH-Index: 55
view all 3 authors...
Neuroendocrine tumors are considered rare tumors: recently an increased incidence and an improvement in survival were described. We explore distribution, incidence and survival of neuroendocrine tumors using population based registry data. We extracted from the Tuscan Cancer Registry neuroendocrine tumors from 1985–2005, and we evaluated distribution, incidence ad survival according to sex, site of tumor, age and stage at diagnosis. 455 cases of neuroendocrine tumors were identified. The overall...
40 CitationsSource
#1Libby Ellis (Lond: University of London)H-Index: 14
#2Matthew J ShaleH-Index: 1
Last. Michel P ColemanH-Index: 81
view all 3 authors...
OBJECTIVES:The epidemiology of gastrointestinal neuroendocrine tumors (GI-NETs) is poorly understood. Recent analyses have suggested changes in the incidence and distribution of such tumors, but have generally used data sets containing small patient numbers. We aimed to define trends in the epidemio
176 CitationsSource
Cited By7
#1Emanuele Panatta (University of Rome Tor Vergata)H-Index: 7
#2Carlotta Zampieri (University of Rome Tor Vergata)H-Index: 1
Last. Ivano Amelio (University of Nottingham)H-Index: 4
view all 4 authors...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been described, questioning the contribution of its canonical pathway for tumour suppression. These include regulation of alternative cell death modalities (i.e. ferroptosis), cell metabolism and the emergi...
#1Yenny Fernanda Guzmán Ruiz (University of Los Andes)
view all 5 authors...
#1Claudia Ramírez-Rentería (Mexican Social Security Institute)H-Index: 7
#2Aldo Ferreira-Hermosillo (Mexican Social Security Institute)H-Index: 8
Last. Moisés Mercado (Mexican Social Security Institute)H-Index: 27
view all 6 authors...
Although neuroendocrine neoplasms (NEN) were once thought to be rare and mostly “benign” diseases, they are now being redefined in light of recently discovered molecular information. NENs constitute a spectrum of variably differentiated neoplasms, ranging from well-differentiated tumors with a protracted course over many years to very aggressive neuroendocrine carcinomas. Although the majority of NEN are non-functional lesions, some of these tumors, do produce a hormonal hypersecretion syndrome....
1 CitationsSource
Background Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) are rare, heterogeneous group which tend to rise in incidence. Epidemiological profile and outcomes of GEP-NEN may vary among countries. The aim of study was to provide baseline clinical and histopathological features of patients with GEP-NEN from tertiary referral hospitals in Latvia.
#1Tobias Else (UM: University of Michigan)H-Index: 32